Later on, Pinna et al. have showed that T1DM patients have higher rates of positive antibodies against MAP/ZnT8 peptides, but failed to find the correlation between the presence of these antibodies and the severity degree of high-risk proliferative diabetic retinopathy24. The gene discussed is SLC30A8; the disease is type 1 diabetes mellitus.